SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern
Sign Up to like & getrecommendations! Published in 2022 at "eLife"
DOI: 10.7554/elife.75537
Abstract: Despite mass public health efforts, the SARS-CoV2 pandemic continues as of late 2021 with resurgent case numbers in many parts of the world. The emergence of SARS-CoV2 variants of concern (VoCs) and evidence that existing… read more here.
Keywords: replicating rna; sars cov2; cov2 variants; variants concern ... See more keywords